Table 2.
For marked fibrosis (≥F2) | For advanced fibrosis (≥F3) | For cirrhosis | |
---|---|---|---|
The intensity difference in the 15-min phase | 0.88 (0.81–0.92) | 0.95 (0.91–0.98) | 0.97 (0.93–0.99) |
FIB4 | 0.85 (0.78–0.91) | 0.89 (0.82–0.94) | 0.90 (0.81–0.96) |
P-values | 0.15 | 0.057 | 0.017 |
Az, area under the receiver operating characteristic curves; marked fibrosis, ≥F2; advanced fibrosis, ≥F3; FIB4, age × AST/(platelet count/ALT0.5); AST (IU/L), aspartate transaminase; ALT (IU/L), alanine transaminase